AIDS Alert Archives – July 1, 2005
July 1, 2005
View Issues
-
Adapting CDC DEBI list for target audiences is a major issue among CBOs
The most recent HIV data show that about 1 million Americans are living with HIV, and the epidemic is becoming more firmly entrenched in the African American community, who now account for 47% of people estimated to be living with HIV. -
DEBI list grows slowly as CBOs adapt models
The Diffusion of Effective Behavioral Interventions (DEBI) list of HIV prevention programs that are evidence-based was compiled by the CDC for the purpose of giving states and community organizations detailed models for providing prevention services. -
Meth’s impact on HIV epidemic being studied
The use of crystal methamphetamines doubles a persons risk for HIV infections, and there has been increasing awareness among public health officials that methamphetamine use is driving new HIV infections, especially among men who have sex with men (MSM), an expert says. -
Antidepressant treatment may improve adherence
While surveying long-term data of HIV-infected people, an investigator was struck by how commonly HIV patients were diagnosed with depression. -
NYC study determines true HIV prevalence
Name-based reporting of HIV infection has been successful in New York City since it was begun in June 2000, but holes still remain in the surveillance system in which thousands of HIV-infected individuals are lost, according to recent research. -
FDA Notifications
The FDA issued an approval on May 31 for a generic formulation of foscarnet sodium injection, 24 mg/mL, 250 mL, and 500 mL single-dose containers, manufactured by Pharmaforce Inc. of Columbus, OH.